Wird geladen...

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019

Abstract Experience in the use of CAR T cells to treat CLL is limited, but safety and efficacy data are encouraging, suggesting that it may be possible to use CAR T cells in populations of CLL patients with particularly unfavorable prognoses. Mechanisms intrinsic to the pathophysiology of CLL undoub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Richard Lemal, Olivier Tournilhac
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2019-08-01
Schriftenreihe:Journal for ImmunoTherapy of Cancer
Schlagworte:
CLL
Online Zugang:http://link.springer.com/article/10.1186/s40425-019-0686-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!